Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program

EMAGIX INC.

$74,936.00

Improving the Measurement of Retinal Blood Vessel Leakage and Perfusion

FY 2026-27 · 2026-04-01

Summary
Diseased blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy, which collectively affect 380 million individuals worldwide. The primary mechanisms that drive vision loss in these diseases are well-known: (i) leakage from retinal blood vessels, and (ii) reduced blood supply to retinal tissue. The aim is ultimately to develop a robust method for measuring leakage from retinal blood vessels and reduced retinal blood supply, to allow accurate monitoring of these abnormalities during patient follow-up and in response to treatment.
Program
Industrial Research Assistance Program
Recipient
Location
Halifax|Halifax, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
788528321
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2027-06-11
Agreement Number
1040532
Agreement Start Date
2026-04-01
Agreement Title
Improving the Measurement of Retinal Blood Vessel Leakage and Perfusion
Agreement Title (French)
Amélioration de la mesure des fuites des vaisseaux sanguins rétiniens et de la perfusion
Agreement Type
Contribution
Agreement Value
$74,936.00
Amendment Number
0
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
Diseased blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy, which collectively affect 380 million individuals worldwide. The primary mechanisms that drive vision loss in these diseases are well-known: (i) leakage from retinal blood vessels, and (ii) reduced blood supply to retinal tissue. The aim is ultimately to develop a robust method for measuring leakage from retinal blood vessels and reduced retinal blood supply, to allow accurate monitoring of these abnormalities during patient follow-up and in response to treatment.
Description (French)
Les anomalies des vaisseaux sanguins rétiniens constituent la principale cause de perte de vision dans des maladies telles que la dégénérescence maculaire liée à l’âge et la rétinopathie diabétique, qui touchent au total 380 millions de personnes dans le monde. Les principaux mécanismes à l’origine de la perte de vision dans ces maladies sont bien connus : (i) les fuites au niveau des vaisseaux sanguins rétiniens, et (ii) la diminution de l’apport sanguin vers les tissus rétiniens. L’objectif final est de mettre au point une méthode fiable pour mesurer les fuites des vaisseaux sanguins rétiniens et la diminution de l’apport sanguin à la rétine, afin de permettre un suivi précis de ces anomalies pendant le suivi des patients et en réponse au traitement.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Halifax
Federal Riding (French)
Halifax
Federal Riding Number
12005
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
788528321
Recipient City
Halifax|Halifax
Recipient Country
CA
Recipient Legal Name
EMAGIX INC.
Recipient Postal Code
B3H 0A8
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2025-2026-Q4-1040532